Investors’ Deck

Get the most up-to-date information on Inhibrx.

Review the most recent status on our pipeline progress.

Download deck

Board Committees

The grid below provides an overview of the individuals that make up each of Inhibrx’s current committees.

Chair Member
Audit Committee
Compensation Committee
Nominating & Corporate Governance Committee
Douglas G. Forsyth
Jon Faiz Kayyem, Ph.D.
Kimberly Manhard
Inhibrx Block 06

Governance Documents

    Investor FAQs

    On what stock exchange are Inhibrx’s shares traded, what is the ticker symbol and when did the company go public?

    Inhibrx trades on the NASDAQ Global Market under the stock symbol INBX. The company’s initial public offering (IPO) priced on August 19, 2020.

    Where is Inhibrx’s corporate headquarters?

    11025 North Torrey Pines Road, Suite 200, La Jolla, CA 92037
    View on Google Maps

    When does Inhibrx’s fiscal year end?

    The company’s fiscal year ends on December 31st.

    Does Inhibrx pay dividends?

    Inhibrx does not expect to declare or pay any cash or other dividends on our common stock.

    Does Inhibrx have a direct stock purchase plan?

    Inhibrx does not currently have a direct stock purchase plan.

    Where can I find all of Inhibrx’s SEC filings? Where can I download and view annual and quarterly reports?

    Quarterly and annual reports, as well as other SEC filings, can be accessed via the SEC Filings section on this page or directly from the SEC at www.sec.gov.

    Who is Inhibrx’s transfer agent and who do I contact with questions about my stock certificates? How can I contact Inhibrx’s transfer agent?

    Continental Stock Transfer & Trust
    1 State Street, 30th Floor
    New York, NY 10004-1561
    cstmail@continentalstock.com

    Analyst Coverage

    Below is a list of individuals that we’re aware of that currently follow Inhibrx. Please note that any opinions, estimates, or forecasts regarding performance made by these analysts don’t represent Inhibrx or its management team.